XML 23 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION
Stock Options and Awards
The Company’s equity incentive program is a long-term retention program that is intended to attract, retain, and provide incentives for talented employees, consultants, officers, and directors and to align stockholder and employee interests. The Company may grant time based options, market condition based options, stock appreciation rights, restricted stock, restricted stock units (“RSUs”), performance shares, performance units, and other stock-based or cash-based awards to employees, officers, directors, and consultants. Under this program, stock options may be granted at prices not less than the fair market value on the date of grant for stock options. These options generally vest over four years and expire from seven to ten years from the date of grant. In addition to time based vesting, market condition based options are subject to a market condition: the closing price of the Company stock must exceed a certain level for a number of trading days within a specified timeframe or the options will be cancelled before the expiration of the options. On June 2, 2017, the Company's stockholders approved an increase to the number of shares reserved for issuance by 3,476,850 shares. Restricted stock generally vests over one year. RSUs generally vest over three years. Awards granted other than an option or stock appreciation right reduce the common stock shares available for grant under the program by 1.75 shares for each share issued.
 
September 30, 2017
Common stock shares available for grant
2,867,585

Standard and market condition stock options outstanding
3,815,784

Restricted stock awards outstanding
44,538

RSU's outstanding
627,454


Employee Stock Purchase Plan
The Company has an Employee Stock Purchase Plan (“ESPP”). Under the ESPP, eligible employees may purchase common stock through payroll deductions at a purchase price of 85% of the lower of the fair market value of the Company’s common stock at the beginning of the offering period or the purchase date. Participants may not purchase more than 2,000 shares in a six-month offering period or purchase stock having a value greater than $25,000 in any calendar year as measured at the beginning of the offering period. A total of 1,000,000 shares of common stock has been reserved for issuance under the ESPP. As of September 30, 2017, 698,133 shares had been purchased since the inception of the ESPP in 1999. Under ASC 718-10, the ESPP is considered a compensatory plan and the Company is required to recognize compensation cost related to the fair value of the award purchased under the ESPP. Shares purchased under the ESPP for the nine months ended September 30, 2017 are listed below. Shares purchased under the ESPP for the nine months ended September 30, 2016 are 45,825. The intrinsic value listed below is calculated as the difference between the market value on the date of purchase and the purchase price of the shares.
 
 
 
Nine Months Ended September 30, 2017
Shares purchased under ESPP
48,750

Average price of shares purchased under ESPP
$
6.74

Intrinsic value of shares purchased under ESPP
$
136,000


Summary of Standard Stock Options
The following table sets forth the summary of activity with respect to standard stock options granted under the Company’s stock option plans for the nine months ended September 30, 2017:
 
 
Nine Months Ended September 30, 2017
Beginning outstanding balance
 
3,421,121

Granted
 
326,978

Exercised
 
(58,023
)
Forfeited
 
(70,306
)
Expired
 
(149,816
)
Ending outstanding balance
 
3,469,954

Aggregate intrinsic value of options exercised
 
$
134,000

Weighted average fair value of options granted
 
3.96



The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the exercise price of the Company’s common stock for the options that were in-the-money.
Information regarding these standard stock options outstanding at September 30, 2017 is summarized below:
 
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (years)
 
Aggregate
Intrinsic
Value
(in millions)
September 30, 2017
 
 
 
 
 
 
 
 
Options outstanding
 
3,469,954

 
$
8.21

 
3.62
 
$
3.4

Options vested and expected to vest using estimated forfeiture rates
 
3,314,281

 
8.18

 
3.52
 
3.3

Options exercisable
 
2,417,385

 
7.94

 
2.86
 
3.2


Summary of Market Condition Based Stock Options
The following table sets forth activity with respect to market condition based stock options granted under the Company’s stock option plans for the nine months ended September 30, 2017:
 
 
Nine Months Ended September 30, 2017
Beginning outstanding balance
 
225,000

Granted
 
120,830

Exercised
 

Canceled
 

Ending outstanding balance
 
345,830

Aggregate intrinsic value of options exercised
 
$


Information regarding these market condition based stock options outstanding at September 30, 2017 is summarized below:
 
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life (years)
 
Aggregate
Intrinsic
Value
(in millions)
September 30, 2017
 
 
 
 
 
 
 
 
Options outstanding
 
345,830

 
$
8.48

 
5.42
 
$

Options vested and expected to vest using estimated forfeiture rates
 
324,033

 
8.47

 
5.38
 

Options exercisable
 
93,750

 
8.09

 
4.42
 


Summary of Restricted Stock Units
RSU activity for the nine months ended September 30, 2017 was as follows:
 
 
Nine Months Ended September 30, 2017
Beginning outstanding balance
 
427,192

Awarded
 
433,015

Released
 
(181,392
)
Forfeited
 
(51,361
)
Ending outstanding balance
 
627,454

Weighted average fair value on grant date of RSUs
 
$
8.46

Total fair value of RSUs released
 
1,853,000


Information regarding RSUs outstanding at September 30, 2017 is summarized below:
 
 
Number of
Shares
 
Weighted
Average
Remaining
Contractual
Life (years)
 
Aggregate
Intrinsic
Value
(in millions)
September 30, 2017
 
 
 
 
 
 
RSUs outstanding
 
627,454

 
1.40
 
$
5.1

RSUs vested and expected to vest using estimated forfeiture rates
 
507,542

 
1.28
 
4.1


Summary of Restricted Stock Awards
Restricted stock award activity for the nine months ended September 30, 2017 was as follows:
 
 
Nine Months Ended September 30, 2017
Beginning outstanding balance
 
77,540

Awarded
 
44,538

Released
 
(77,540
)
Forfeited
 

Ending outstanding balance
 
44,538

Weighted average grant date fair value of restricted stock awarded
 
$
8.65

Total fair value of restricted stock awards released
 
671,000


Stock Plan Assumptions
The assumptions used to value option grants under the Company’s stock plans were as follows:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2017
 
2016
 
2017
 
2016
Standard Stock Options
 
 
 
 
 
 
 
 
Expected life (in years)
 
4.6

 
4.5

 
4.5

 
4.5

Volatility
 
53
%
 
55
%
 
53
%
 
55
%
Interest rate
 
1.7
%
 
0.8
%
 
1.7
%
 
1.1
%
Dividend yield
 
N/A

 
N/A

 
N/A

 
N/A


 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2017
 
2016
 
2017
 
2016
Market Condition Based Stock Options
 
 
 
 
 
 
 
 
Expected life (in years)
 
N/A
 
N/A
 
7.0

 
7.0

Volatility
 
N/A
 
N/A
 
55
%
 
59
%
Interest rate
 
N/A
 
N/A
 
2.0
%
 
1.6
%
Dividend yield
 
N/A
 
N/A
 
N/A

 
N/A

 
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2017
 
2016
 
2017
 
2016
Employee Stock Purchase Plan
 
 
 
 
 
 
 
 
Expected life (in years)
 
0.5

 
0.5

 
0.5

 
0.5

Volatility
 
46
%
 
53
%
 
48
%
 
53
%
Interest rate
 
1.1
%
 
0.4
%
 
0.9
%
 
0.4
%
Dividend yield
 
N/A

 
N/A

 
N/A

 
N/A


Compensation Costs
Total stock-based compensation recognized in the condensed consolidated statements of operations and comprehensive income (loss) is as follows:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2017
 
2016
 
2017
 
2016
 
 
(In thousands)
Statement of Operations Classifications
 
 
 
 
 
 
 
 
Sales and marketing
 
$
317

 
$
335

 
$
808

 
$
895

Research and development
 
231

 
257

 
780

 
1,041

General and administrative
 
790

 
622

 
2,485

 
2,867

Total
 
$
1,338

 
$
1,214

 
$
4,073

 
$
4,803



As of September 30, 2017, there was $7.3 million of unrecognized compensation cost, adjusted for estimated forfeitures, related to non-vested stock options, restricted stock awards and RSUs granted to the Company’s employees and directors. This cost will be recognized over an estimated weighted-average period of approximately 2.27 years for standard options, 2.33 years for market condition based options, 2.37 years for RSUs, and 0.67 years for restricted stock awards. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures.